orphan reach™– the first global Contract Research Organisation (CRO) purely dedicated to rare diseases.
We are here to accelerate the clinical development of orphan drugs and facilitate patient access to urgently needed new treatments for rare conditions.
For our customers – innovative biotech companies – we provide global CRO services with particular attention to patient recruitment and retention enhanced by home nursing and patient travel support. As an organization that is used to operate trials in small patient populations we have developed the required translatable skills and understanding of the challenges of rare diseases that make us stand out from the crowd.
Our infrastructure allows access to patients with rare diseases in more than 100 countries world-wide. With centrally based Project Management teams in Europe, USA and Asia we co-ordinate our workforce on the ground in each of the local territories and contribute our orphan expertise to accelerate access to new drugs in a wide range of therapeutic areas.